Home » Stocks » Nutriband

Nutriband Inc. (NTRB)

Stock Price: $10.25 USD 0.00 (0.00%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 56.51M
Revenue (ttm) 296,421
Net Income (ttm) -2.56M
Shares Out 5.51M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $10.25
Previous Close $10.25
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 10.25 - 10.25
Day's Volume 57
52-Week Range 8.00 - 40.00

More Stats

Market Cap 56.51M
Enterprise Value 56.50M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 5.51M
Float 2.43M
EPS (basic) -0.47
EPS (diluted) -0.47
FCF / Share -0.15
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta -0.89
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 190.64
PB Ratio 38.34
Revenue 296,421
Operating Income -1.54M
Net Income -2.56M
Free Cash Flow -823,431
Net Cash 6,867
Net Cash / Share 0.00
Gross Margin -60.20%
Operating Margin -520.80%
Profit Margin -863.80%
FCF Margin -277.79%
ROA -40.91%
ROE -144.00%
ROIC 277.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: 10.25
Target: 48.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth51.11%---
Gross Profit-0.18-0.04--
Operating Income-1.97-3.33-2.67-0.15
Net Income-2.72-3.33-2.67-0.15
Shares Outstanding5.425.354.805.30
Earnings Per Share-0.50-0.62-0.56-0.04
Operating Cash Flow-0.89-1.11-0.09-0.15
Capital Expenditures----
Free Cash Flow-0.89-1.11-0.09-0.15
Cash & Equivalents0.010.470.000.03
Total Debt0.320.040.02-
Net Cash / Debt-0.310.43-0.020.03
Book Value0.182.400.120.02
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Nutriband Inc.
Country United States
Employees 3
CEO Gareth R. Sheridan

Stock Information

Ticker Symbol NTRB
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: NTRB


Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS patch line; a sleep patch line; and a nausea and motion sickness patch line. The company was incorporated in 2016 and is headquartered in Orlando, Florida.